
陳明,神經(jīng)生物學(xué)博士,副教授,博士生導(dǎo)師
2024-2025年度中國(guó)科學(xué)技術(shù)大學(xué)心理學(xué)系訪問(wèn)學(xué)者。現(xiàn)任藥學(xué)科學(xué)學(xué)院藥理學(xué)教研室黨支部副書(shū)記、第二附屬醫(yī)院耳鼻喉科學(xué)術(shù)副主任(校院雙聘),并掛職人力資源部(教師工作部、人才工作辦公室)部長(zhǎng)助理。入選安徽省教育廳優(yōu)秀青年教師培育重點(diǎn)項(xiàng)目、安徽醫(yī)科大學(xué)青年英才“雙培工程”、安徽醫(yī)科大學(xué)“東南人才工程”四類人才。安徽省藥理學(xué)會(huì)青年委員,中國(guó)藥理學(xué)會(huì)會(huì)員,中國(guó)神經(jīng)科學(xué)學(xué)會(huì)會(huì)員。Phytomedicine,Heliyon等多個(gè)國(guó)際期刊審稿人,國(guó)家自然科學(xué)基金項(xiàng)目函審專家。主要研究阿爾茨海默癥、抑郁癥等神經(jīng)精神系統(tǒng)疾病發(fā)病機(jī)制及藥物干預(yù)。主持國(guó)家自然科學(xué)基金2項(xiàng),省部級(jí)項(xiàng)目多項(xiàng)。在Molecular Neurodegeneration、Research、eLife、Brain Behavior and Immunity、Phytomedicine、Cerebral Cortex等期刊發(fā)表SCI論文20余篇。截至目前已指導(dǎo)碩士研究生十余人,獲國(guó)家獎(jiǎng)學(xué)金、校“三好研究生”“優(yōu)秀研究生干部”及研究生獎(jiǎng)學(xué)金等多人。指導(dǎo)本科生發(fā)表SCI論文4篇,指導(dǎo)國(guó)家級(jí)大創(chuàng)項(xiàng)目3項(xiàng),省級(jí)大創(chuàng)項(xiàng)目3項(xiàng)。
聯(lián)系方式
郵箱:chenming@ahmu.edu.cn
研究方向
1. 阿爾茨海默癥、抑郁癥等神經(jīng)精神系統(tǒng)疾病發(fā)病機(jī)制及干預(yù)靶點(diǎn)研究
2. 靶向小膠質(zhì)細(xì)胞納米藥物載體構(gòu)建
主持的科研項(xiàng)目
1.2024.01-2027.12,國(guó)家自然科學(xué)基金面上項(xiàng)目(No. 82371541)
2.2019.01-2021.12,國(guó)家自然科學(xué)基金青年基金項(xiàng)目(No. 81801064)
3. 2025.01-2027.12,安徽省教育廳優(yōu)秀青年教師培育重點(diǎn)項(xiàng)目(No. YQZD2024007)
4. 2024.01-2026.12, 安徽醫(yī)科大學(xué)基礎(chǔ)與臨床合作研究提升計(jì)劃培育專項(xiàng)(No. 2023sfy010)
5. 2023.01-2025.12,安徽省轉(zhuǎn)化醫(yī)學(xué)培育項(xiàng)目(No. 2022zhyx-C11)
6. 2023.01-2025.12,安徽醫(yī)科大學(xué)優(yōu)秀青年骨干教師培養(yǎng)計(jì)劃(No. 2022YPJH201)
7. 2022.01-2024.12,安徽醫(yī)科大學(xué)科研水平提升計(jì)劃(No. 2021xkjT003)
8. 2018.01-2020.12,安徽醫(yī)科大學(xué)博士科研啟動(dòng)基金(No. XJ201722)
9. 2020.01-2022.12,校企合作橫向課題(No. 2020176)
主持的教學(xué)項(xiàng)目
1. 安徽省質(zhì)量工程虛擬仿真實(shí)驗(yàn)教學(xué)項(xiàng)目——膜片鉗技術(shù)虛擬仿真實(shí)驗(yàn)教學(xué)項(xiàng)目,2021xnfzxm052,2022.04-2024.04,結(jié)題,主持。(二類教學(xué)課題)
2. 新時(shí)代育人省級(jí)質(zhì)量工程研究生教育教學(xué)改革研究項(xiàng)目,2024jyjxggyjY151,2025.02-2027.02,在研,主持。(三類教學(xué)課題)
論文與專著(# equal contribution; * Corresponding author)
1. COG133 ameliorates depression-like behaviors in mice by inhibiting p38 MAPK-mediated neuroinflammation. (Under revision in Brain Behavior and Immunity). 通訊作者.中科院一區(qū)TOP, IF=7.6
2. Oral self-assembled nanomedicine orchestrates hierarchical regulation of the lipid–ROS–inflammation cascade for comprehensive therapy of non-alcoholic fatty liver disease. (Under revision in Chemical Engineering Journal). 通訊作者, 中科院一區(qū)TOP, IF=13.2
3. Sleep Deprivation induces Mania-like Behaviors in Mice by Regulating DA/GSK-3β Signaling. (Under review in Neuropharmacology). 通訊作者
4. Modulation of Synaptic Targets by Psilocybin in Neurological Disorders: Integrated Network Pharmacology and Transcriptomic Validation. (Under review in Computational Biology and Chemistry). 通訊作者
5. Sleep Deprivation Induces Anxiety-like Behaviors in Mice by Impairing ApoE/AMPK/mTOR-Mediated Autophagy. Molecular Neurobiology. 2025 Dec 13;63(1):293.通訊作者
6. Targeting the Complement-mTOR-Autophagy Axis: The Role of Apolipoprotein E in Depression. BMC Biology. 2025 Jul 28;23(1):228.通訊作者
7. Targeting ApoE-KCC2 Signaling Rescues GABAergic Synaptic Dysfunction and Depression-like Behaviors in Mice. Research.2025 Jun 17:8:0746.通訊作者. IF=10.9,中科院一區(qū)TOP
8. High-fat Fructose diet induces neuroinflammation and anxiety-like behaviors by modulating liver-brain axis communication. Psychopharmacology(Berl).2025 Dec;242(12):2651-2664.通訊作者
9. The Role of Lipoprotein and Gut Microbiome in Alzheimer's Disease: A Review of Novel Findings and Potential Applications. Current Alzheimer Research.2025 Oct 24.doi: 10.2174/0115672050407276251014113234. Online ahead of print.通訊作者
10. Dysregulation of parvalbumin expression and neurotransmitter imbalance in the auditory cortex of the BTBR mouse model of autism spectrum disorder. Developmental Neurobiology. 2024 Oct;84(4):251-263.通訊作者
11. The relationship between hypoxia and Alzheimer’s disease: an updated review. Front. Aging Neurosci. 2024,16:1402774. 通訊作者
12. Cognitive Impairment in Alzheimer's Disease FAD4TMouse Model: Synaptic Loss Facilitated by Activated Microglia via C1qa. Life Sciences. 2024 Mar; 340:122457. 通訊作者
13. Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review. Neurochemical Research. 2024 Mar;49(3):568-582.通訊作者
14. Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review. Neuroscience. 2023 Mar 15;514:123-140. 通訊作者
15. Shufengjiedu capsule ameliorates olfactory dysfunction via mediating AMPK/mTOR-autophagy pathway in a mouse model of allergic rhinitis. Phytomedicine. 2022 Dec 107:154426.中科院一區(qū)TOP,IF=7.9 通訊作者
16. High fat diet-induced obesity leads to depressive and anxiety-like behaviors in mice via AMPK/mTOR-mediated autophagy. Experimental Neurology. 2022 Feb;348:113949. 通訊作者
17.Enhancing GABAergic signaling ameliorates aberrant gamma oscillation of olfactory bulb in AD mouse models. Molecular Neurodegeneration. 2021 Mar 4;16(1):14. 中科院一區(qū)TOP,IF=18.9,第一作者
18. Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice.Journal of Ginseng Research. 2021 Nov; 45(6): 665-675. 中科院一區(qū),共同第一作者
19. Soluble b-amyloid impaired the GABA inhibition by mediating KCC2 in early APP/PS1 mice. BioSci Trends. 2021 Nov 21;15(5):330-340. IF=9.1通訊作者
20. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. Life Sciences. 2020 Jul 1;252:117601. 通訊作者
21. APP modulates KCC2 expression and function in hippocampal GABAergic inhibition.eLife.2017, 6: e20142.中科院一區(qū)TOP,第一作者
22. Prefrontal cortical GABAergic dysfunction contributes to aberrant UP-state duration in APP knockout mice. Cerebral Cortex. 2017, 27(8): 4060-4072. 中科院一區(qū)TOP,共同第一作者
23. Altered striatal rhythmic activity in cylindromatosis knock-out mice due to enhanced GABAergic inhibition. Neuropharmacology. 2016, 100(Pt A):260-267. 中科院一區(qū)TOP,共同第一作者
專利與技術(shù)許可
1.國(guó)家級(jí)實(shí)用新型專利,一種快速塑料槍頭裝載器,2022230924738,陶博睿,陳明,張翠等。
榮譽(yù)與獎(jiǎng)勵(lì)
1.2024年度安徽醫(yī)科大學(xué)“優(yōu)秀教師”
2.2024年度安徽省“優(yōu)秀青年研究生導(dǎo)師”
3.2023年度安徽醫(yī)科大學(xué)“優(yōu)秀研究生導(dǎo)師”
4.2023年度安徽醫(yī)科大學(xué)“復(fù)元科技新星”
5.2022年度安徽醫(yī)科大學(xué)“優(yōu)秀共產(chǎn)黨員”
6.2022年度安徽醫(yī)科大學(xué)“學(xué)習(xí)雷鋒在行動(dòng)”先進(jìn)個(gè)人
7.2021-2022年度安徽醫(yī)科大學(xué)“優(yōu)秀班主任”
8.指導(dǎo)本科生發(fā)表SCI論文4篇,主持國(guó)家級(jí)大創(chuàng)3項(xiàng),省級(jí)大創(chuàng)3項(xiàng)
9.指導(dǎo)本科生獲安徽省生物標(biāo)本大賽省級(jí)三等獎(jiǎng)
10.指導(dǎo)本科生獲安徽省食品設(shè)計(jì)大賽省級(jí)二等獎(jiǎng)
11.指導(dǎo)本科生獲安徽省基礎(chǔ)醫(yī)學(xué)實(shí)驗(yàn)技能大賽省賽銀獎(jiǎng)
12.指導(dǎo)本科生獲安徽醫(yī)科大學(xué)2022年“挑戰(zhàn)杯”大學(xué)生創(chuàng)業(yè)計(jì)劃競(jìng)賽校園賽二等獎(jiǎng)
13.指導(dǎo)研究生獲批2024年度校級(jí)研究生科研與實(shí)踐創(chuàng)新項(xiàng)目
14.指導(dǎo)研究生獲批2023年度校級(jí)研究生科研與實(shí)踐創(chuàng)新項(xiàng)目
15.指導(dǎo)研究生獲2021-2022年度“國(guó)家獎(jiǎng)學(xué)金”、“三好研究生”等榮譽(yù)
16.指導(dǎo)本科生獲第九屆中國(guó)國(guó)際“互聯(lián)網(wǎng)+”大學(xué)生創(chuàng)新創(chuàng)業(yè)大賽安徽醫(yī)科大學(xué)校賽一等獎(jiǎng)
17.指導(dǎo)本科生獲安徽醫(yī)科大學(xué)第十一屆大學(xué)生基礎(chǔ)醫(yī)學(xué)實(shí)驗(yàn)技能大賽二等獎(jiǎng)